In accordance with the provisions of the by number 5/204/2000 as in effect and the 3/347/2005 Decisions of the B.D. of the Capital Stock Commission and further to its prior announcements, Euromedica S.A. announces to the investing public the following:
Our company on 7/20/2007 proceeded to the issue of a convertible bond loan of a total amount of Euro 60.1 million, divided into 601 bonds of a face value of Euro 100,000 each, of a five year term, with a fixed interest rate of 3.6%, return at the expiration of 5.6% and initial conversion price of Euro 10.36 per share (hereby, the Bonds).
Of the above Bonds, the subsidiary of the Company, Euromedica Finance 1 S.A. headquartered in Luxemburg, acquired 600 Bonds of a value of sixty million Euros (Euro 60,000,000) with yields that came from the simultaneous issue of 600 exchangeable bonds, of a face value of Euro 100,000 each (hereby, the Exchangeable Bonds), of a total amount of Euro 60 million, of a five year term, with a fixed interest rate of 3.6% and return at the expiration of 5.6%. The deposit of capital and interest for the Exchangeable Bonds is guaranteed by the Company. The Exchangeable Bonds, provided the exchange right is exercised, will be converted to Bonds which, in their turn, will be converted to shares of the Company. The Exchangeable Bonds will be introduced within 3 months for trading in the Luxemburg Stock Exchange.
The Exchangeable Bonds were acquired from investment funds managed by CQS (UK) LLP.
In the framework of the above convertible bond loan, the company AXON AXE purchased one Bond for Euro 100,000.